FluroTech Ltd. (FLURF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 408.08 Thousand CAD | -18.91% |
| 2022 | 503.22 Thousand CAD | 6.0% |
| 2021 | 474.74 Thousand CAD | 64.2% |
| 2020 | 289.12 Thousand CAD | -48.75% |
| 2019 | 564.12 Thousand CAD | 7.93% |
| 2018 | 522.66 Thousand CAD | 2513.57% |
| 2017 | 19.99 Thousand CAD | -11.01% |
| 2016 | 22.47 Thousand CAD | 22.99% |
| 2015 | 18.27 Thousand CAD | -16.51% |
| 2014 | 21.88 Thousand CAD | 9.44% |
| 2013 | 19.99 Thousand CAD | -54.16% |
| 2012 | 43.62 Thousand CAD | 118.12% |
| 2011 | 20 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 653.41 Thousand CAD | 60.12% |
| 2024 Q2 | 494.96 Thousand CAD | -24.25% |
| 2023 FY | 408.08 Thousand CAD | -18.91% |
| 2023 Q4 | 408.08 Thousand CAD | -11.3% |
| 2023 Q2 | 413.37 Thousand CAD | 1.41% |
| 2023 Q3 | 460.07 Thousand CAD | 11.3% |
| 2023 Q1 | 407.63 Thousand CAD | -19.0% |
| 2022 Q4 | 503.22 Thousand CAD | -5.16% |
| 2022 Q3 | 530.61 Thousand CAD | 4.12% |
| 2022 Q1 | 475.46 Thousand CAD | 0.15% |
| 2022 FY | 503.22 Thousand CAD | 6.0% |
| 2022 Q2 | 509.61 Thousand CAD | 7.18% |
| 2021 Q1 | 231.5 Thousand CAD | -19.93% |
| 2021 Q3 | 715.92 Thousand CAD | -10.63% |
| 2021 FY | 474.74 Thousand CAD | 64.2% |
| 2021 Q4 | 474.74 Thousand CAD | -33.69% |
| 2021 Q2 | 801.06 Thousand CAD | 246.02% |
| 2020 Q3 | 265.33 Thousand CAD | -32.02% |
| 2020 Q4 | 289.12 Thousand CAD | 8.97% |
| 2020 Q1 | 413.42 Thousand CAD | -26.71% |
| 2020 FY | 289.12 Thousand CAD | -48.75% |
| 2020 Q2 | 390.33 Thousand CAD | -5.58% |
| 2019 Q3 | 409.02 Thousand CAD | -12.87% |
| 2019 Q4 | 564.12 Thousand CAD | 37.92% |
| 2019 FY | 564.12 Thousand CAD | 7.93% |
| 2019 Q1 | 289.12 Thousand CAD | -44.68% |
| 2019 Q2 | 469.46 Thousand CAD | 62.37% |
| 2018 Q2 | 352.7 Thousand CAD | 1159.01% |
| 2018 FY | 522.66 Thousand CAD | 2513.57% |
| 2018 Q4 | 522.66 Thousand CAD | -29.07% |
| 2018 Q3 | 736.86 Thousand CAD | 108.92% |
| 2018 Q1 | 28.01 Thousand CAD | 40.08% |
| 2017 Q4 | 19.99 Thousand CAD | 36.4% |
| 2017 FY | 19.99 Thousand CAD | -11.01% |
| 2017 Q3 | 14.66 Thousand CAD | 83.26% |
| 2017 Q2 | 8000.00 CAD | -64.28% |
| 2017 Q1 | 22.39 Thousand CAD | -0.32% |
| 2016 FY | 22.47 Thousand CAD | 22.99% |
| 2016 Q1 | 24.88 Thousand CAD | 36.17% |
| 2016 Q2 | 9499.00 CAD | -61.82% |
| 2016 Q4 | 22.47 Thousand CAD | 72.87% |
| 2016 Q3 | 12.99 Thousand CAD | 36.85% |
| 2015 Q3 | 14.35 Thousand CAD | 35.65% |
| 2015 Q2 | 10.58 Thousand CAD | -53.77% |
| 2015 FY | 18.27 Thousand CAD | -16.51% |
| 2015 Q4 | 18.27 Thousand CAD | 27.27% |
| 2015 Q1 | 22.89 Thousand CAD | 4.6% |
| 2014 Q3 | 14.24 Thousand CAD | -18.58% |
| 2014 Q4 | 21.88 Thousand CAD | 53.61% |
| 2014 Q2 | 17.49 Thousand CAD | 42.86% |
| 2014 FY | 21.88 Thousand CAD | 9.44% |
| 2014 Q1 | 12.24 Thousand CAD | -38.75% |
| 2013 Q4 | 19.99 Thousand CAD | 45.45% |
| 2013 Q3 | 13.74 Thousand CAD | 0.55% |
| 2013 Q2 | 13.67 Thousand CAD | -71.5% |
| 2013 Q1 | 47.97 Thousand CAD | 9.96% |
| 2013 FY | 19.99 Thousand CAD | -54.16% |
| 2012 Q2 | 5522.00 CAD | -64.85% |
| 2012 Q1 | 15.71 Thousand CAD | -21.44% |
| 2012 Q4 | 43.62 Thousand CAD | 411.96% |
| 2012 FY | 43.62 Thousand CAD | 118.12% |
| 2012 Q3 | 8521.00 CAD | 54.31% |
| 2011 Q2 | 23.48 Thousand CAD | -31.47% |
| 2011 Q4 | 20 Thousand CAD | 233.33% |
| 2011 Q1 | 34.26 Thousand CAD | 0.0% |
| 2011 FY | 20 Thousand CAD | 0.0% |
| 2011 Q3 | 6000.00 CAD | -74.45% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 2.11 Million USD | 80.732% |
| Össur hf. | 688.8 Million USD | 99.941% |
| QHSLab, Inc. | 2.05 Million USD | 80.162% |
| Wellstar International, Inc. | 55.99 Million USD | 99.271% |
| Össur hf. | 688.8 Million USD | 99.941% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | 86.159% |
| Aurora Spine Corporation | 6.65 Million USD | 93.867% |
| BrainsWay Ltd. | 15.31 Million USD | 97.335% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 19.86 Million USD | 97.946% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 99.11% |
| BioElectronics Corporation | 16.62 Million USD | 97.545% |
| Vivos Inc. | 245 Thousand USD | -66.563% |
| Kelyniam Global, Inc. | 1.01 Million USD | 59.713% |
| Zecotek Photonics Inc. | 5.86 Million USD | 93.046% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -48.064% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 97.462% |
| Avitar, Inc. | 11.59 Million USD | 96.48% |
| Nanomix Corporation | 14.81 Million USD | 97.245% |
| Theraclion SA | 13.01 Million EUR | 96.865% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 92.036% |
| NewCardio, Inc. | 6.01 Million USD | 93.213% |
| Positron Corporation | 2.02 Million USD | 79.858% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 88.731% |
| Lombard Medical, Inc. | 53.79 Million USD | 99.241% |
| ALR Technologies Inc. | 24.5 Million USD | 98.335% |
| Stratec SE | 271.97 Million USD | 99.85% |
| Vycor Medical, Inc. | 4.31 Million USD | 90.549% |
| Heart Tronics, Inc. | 1.09 Million USD | 62.725% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 82.699% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.984% |
| VMS Rehab Systems, Inc. | 201.36 USD | -202564.879% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 92.546% |
| Ingen Technologies, Inc. | 5.7 Million USD | 92.853% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 83.342% |
| Odyssey Group International, Inc. | 6.61 Million USD | 93.828% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 99.378% |
| IR-Med Inc. | 634 Thousand USD | 35.633% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 92.549% |
| United American Healthcare Corporation | 119 Thousand USD | -242.929% |
| Polarean Imaging plc | 2.58 Million USD | 84.186% |
| ECGI Holdings, Inc. | 11.94 Million USD | 96.582% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 69.177% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 71.785% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 39.776% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 92.437% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 95.189% |
| SS Innovations International, Inc. | 11.18 Million USD | 96.35% |
| Urologix, Inc. | 12.64 Million USD | 96.772% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 22.327% |
| Smith & Nephew plc | 4.76 Billion USD | 99.991% |
| NIOX Group Plc | 9.8 Million USD | 95.837% |
| Fuse Medical, Inc. | 15.11 Million USD | 97.299% |
| Broncus Holding Corporation | 10.43 Million USD | 96.088% |
| Brain Scientific Inc. | 7.42 Million USD | 94.505% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 98.793% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 48.609% |